Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts

Laboratory Investigation - Tập 92 - Trang 952-966 - 2012
Ines Martin-Padura1, Paola Marighetti1, Alice Agliano1,2, Federico Colombo3, Leyre Larzabal2, Miriam Redrado2, Anne-Marie Bleau2, Celia Prior2, Francesco Bertolini1, Alfonso Calvo2
1Laboratory of Hematology-Oncology, European Institute of Oncology, Milan, Italy
2Oncology Division, Laboratory of Novel Therapeutic Targets, CIMA of the University of Navarra, Pamplona, Spain
3Laboratory of Cytometry and Hepatology, Fondazione Ospedale Maggiore Policlinico, Milan, Italy

Tài liệu tham khảo